About

Emgrast 300mcg injection contains filgrastim as its active ingredient. It is a granulocyte-colony stimulating factor (G-CSF) and a type of white blood cell growth factor approved by the FDA. This medication is primarily used to lower the risk of febrile neutropenia—a condition involving fever or infection associated with a low white blood cell (WBC) count—in patients with non-myeloid cancers undergoing chemotherapy. It also helps shorten the duration of neutropenia (low WBC count) in these individuals.

Additionally, Emgrast 300mcg injection is used to increase WBC levels and reduce the length of fever in patients with acute myeloid leukemia, support recovery in those undergoing bone marrow transplants, and treat individuals with severe chronic neutropenia (a persistently low neutrophil count). It also plays a role in preparing the body for leukapheresis, a procedure that removes specific blood cells. Another important use is to enhance survival chances in people exposed to high levels of radiation, which can severely damage the bone marrow. Emgrast is also used in patients with advanced HIV infection to help reduce the risk of infection.

As a colony-stimulating factor, Emgrast 300mcg injection works by stimulating the body to produce more white blood cells. WBCs are essential for fighting infections, and their levels can drop significantly during chemotherapy. Low WBC counts weaken the immune system, making the body more vulnerable to infections.

Before starting this treatment, inform your physician if you have a history of liver disease, kidney issues, sickle cell anemia, or bone disorders. Common side effects may include fever, pain, rash, cough, shortness of breath, and nosebleeds.

Uses

To prevent infections after chemotherapy due to decreased white blood cells (neutropenia)

Directions for use

This medicine should be administered by a doctor or nurse. Please do not attempt to self-administer it.

Side effects

Common:

Pain in the bones, joints, and muscles
Pain at the site of Injection
Fever
Itchiness and skin rash
Nausea
Headaches
Dizziness and tiredness
Nose bleeding
Hair fall

Serious:

Inflammation of Aorta
Capillary leak syndrome (plasma leaks out of tiny blood vessels)
Hypersensitivity reactions
Changes in urine color
Swelling in hands, feet, face, and abdomen
Difficulty in breathing
Sickle cell anemia

Safety Measures

Alcohol - Consuming alcohol while receiving Emgrast 300mcg injection is considered unsafe. Consult your doctor for personalized advice and guidance regarding alcohol use during treatment.
Pregnancy - Emgrast 300mcg injection is not considered safe during pregnancy, as it may cause birth defects. If you are pregnant or planning to become pregnant during treatment, consult your doctor for appropriate guidance.
Breastfeeding - Breastfeeding is not recommended during treatment with Emgrast 300mcg injection, as the medicine may harm your baby. Please consult your doctor before breastfeeding.
Liver - The safety of Emgrast 300mcg injection in patients with liver disorders is not well established. Inform your physician if you have any liver conditions before starting this treatment.
Kidney - The safety of Emgrast 300mcg injection in patients with kideny conditions is not clearly known. Consult your doctor if you have any related diseases before beginning the treatment.

Disclaimer

Med E Hub is committed to delivering reliable, expert-reviewed information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.

Shipping & Location